Erin Wright Reiterates Hold Rating on Align Technology with Unchanged $188 Price Target Amid Balanced Fundamentals and Macro Risks

Analyst Erin Wright from Morgan Stanley maintained a Hold rating on Align Tech and keeping the price target at $188.00.

Erin Wright has given his Hold rating due to a combination of factors, balancing improving fundamentals with ongoing risks and a valuation she views as fair. The company delivered a solid first quarter, with clear aligner volumes and profitability surpassing expectations, and management reaffirmed its 2026 revenue outlook, which appears attainable given progress in utilization, consumer demand, and patient conversion.

However, she also points to persistent macro headwinds, particularly in North America, and notes that management’s guidance for the second half of the year is deliberately conservative, reflecting limited visibility amid economic uncertainty. While the stock now trades at a discount to its historical earnings multiples, she believes this appropriately captures both the upside from execution and the downside from regional weakness and macro risks, which supports maintaining a Hold rating and an unchanged $188 price target.

In another report released on April 28, Needham also maintained a Hold rating on the stock with a $184.00 price target.